Skip to content
The Policy VaultThe Policy Vault

Natpara — United Healthcare

hypocalcemia resulting from chronic hypoparathyroidism

Initial criteria

  • Diagnosis of hypocalcemia resulting from chronic hypoparathyroidism
  • Patient is on active vitamin D (e.g., calcitriol) therapy prior to starting Natpara
  • Patient is currently on calcium supplementation OR patient has a contraindication to calcium supplementation

Reauthorization criteria

  • Documentation of positive clinical response to Natpara therapy

Approval duration

12 months